Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

March 20, 2014

Kolltan raises $60M from investors

New Haven’s Kolltan Pharmaceuticals said it’s raised $60 million from investors as it prepares to head into clinical trials for its cancer therapy.

Kolltan’s monoclonal antibody technology was created at Yale University.

The company raised the money from 34 investors starting March 13.

A spokesman for the company declined on Thursday afternoon to offer details about how the company would use the money.

Sign up for Enews

Related Content

0 Comments

Order a PDF